Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote GBp

OptiBiotix Health Plc (OPTI.L)

20.00
+2.00
+(11.11%)
At close: May 2 at 4:04:03 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
644
644
457
2,213
1,523.25
Cost of Revenue
324
324
213
1,090
643.43
Gross Profit
320
320
244
1,123
879.82
Operating Expense
2,015
2,015
10,763
2,488
1,991.21
Operating Income
-1,695
-1,695
-10,519
-1,365
-1,111.39
Net Non Operating Interest Income Expense
1
1
--
-48
-44.86
Pretax Income
-2,043
-2,043
2,441
6,177
5,710.23
Tax Provision
-4
-4
-146
-84
-91.64
Net Income Common Stockholders
-2,039
-2,039
2,587
6,261
5,801.87
Diluted NI Available to Com Stockholders
-2,039
-2,039
2,587
6,261
5,801.87
Basic EPS
-0.15
-0.02
0.03
0.07
0.07
Diluted EPS
-0.15
-0.02
0.03
0.07
0.06
Basic Average Shares
88,396.13
90,190.66
88,279.95
87,574.15
87,207.70
Diluted Average Shares
96,920.81
98,273.57
93,213.18
95,536.40
95,569.95
Total Operating Income as Reported
-1,695
-1,695
-2,489
-1,365
-1,111.39
Total Expenses
2,339
2,339
10,976
3,578
2,634.64
Net Income from Continuing & Discontinued Operation
-2,039
-2,039
2,587
6,261
5,801.87
Normalized Income
-2,013.05
-2,013.05
-7,977.83
113.10
-5.78
Interest Income
1
1
--
--
0.10
Interest Expense
--
--
--
48
44.95
Net Interest Income
1
1
--
-48
-44.86
EBIT
-2,043
-2,043
2,441
6,225
5,755.19
EBITDA
-1,838
-1,838
2,665
6,513
6,003.08
Reconciled Cost of Revenue
324
324
213
1,090
643.43
Reconciled Depreciation
205
205
224
288
247.90
Net Income from Continuing Operation Net Minority Interest
-2,039
-2,039
2,587
6,261
5,801.87
Total Unusual Items Excluding Goodwill
-26
-26
13,043
7,590
7,169.93
Total Unusual Items
-26
-26
13,043
7,590
7,169.93
Normalized EBITDA
-1,812
-1,812
-10,378
-1,077
-1,166.85
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-0.05
-0.05
2,478.17
1,442.10
1,362.29
12/31/2020 - 9/9/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SBTX.L SkinBioTherapeutics plc
22.75
-2.15%
 
PBX.AQ ProBiotix Health Plc
6.51
+0.00%
 
IMM.L ImmuPharma plc
3.4400
-1.85%
 
PYC.L Physiomics Plc
0.4200
-1.18%
 
TRX.L Tissue Regenix Group plc
32.80
+5.81%
 
REPL Replimune Group, Inc.
10.01
+3.84%
 
VIGL Vigil Neuroscience, Inc.
2.7500
+7.42%
 
ALXO ALX Oncology Holdings Inc.
0.5329
+3.34%
 
RZLT Rezolute, Inc.
4.0000
+1.01%
 
CRBP Corbus Pharmaceuticals Holdings, Inc.
7.79
+3.59%